7364736B2

2 known cases. View patent page →

Amgen Inc. v. Samsung Bioepis Co., Ltd.

Consent Judgment
Docket:
1:24-cv-08417-CPO-EAP
Terminated:
2026-01-22

A Consent Order and Judgment was entered by stipulation. For the purposes of this action, the asserted claims of all 21 enumerated patents, including US7364736B2, were deemed valid, enforceable, and infringed by Samsung's denosumab biosimilar products.

Untitled case

ongoing
Docket:
1:25-cv-12160
Patents:7364736B2

This is an ongoing patent litigation case in the New Jersey District Court concerning US patent 7364736B2.